Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
K
307750
vs
K
KOSPI 200
Over the past 12 months, Kukjeon Pharmaceutical Co Ltd has underperformed KOSPI 200, delivering a return of -33% compared to KOSPI 200's +56% growth.
Stocks Performance
307750 vs KOSPI 200
Performance Gap
307750 vs KOSPI 200
Performance By Year
307750 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Kukjeon Pharmaceutical Co Ltd
Glance View
Kukjeon Pharmaceutical makes and sells medicines in South Korea. Its business is centered on developing, manufacturing, and supplying pharmaceutical products such as prescription drugs and over-the-counter treatments, along with related health products. The company’s customers are mainly hospitals, clinics, pharmacies, and other drug distributors that buy finished medicines for patients and consumers. The company earns money by selling these products through pharmaceutical sales channels. In practice, that means it turns raw materials and licensed formulas into packaged medicines, then ships them into the healthcare supply chain. Like many drug makers, its business depends on steady demand for treatments that doctors prescribe and pharmacists dispense every day. What makes this business model different is that it sits in the middle of healthcare, not at the point of care. Kukjeon Pharmaceutical does not sell directly to patients; it sells to institutions and distributors that then reach patients. That gives it a role as a manufacturer and supplier in the medicines supply chain, where product quality, regulatory approval, and dependable delivery matter as much as branding.